Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients

NCT02461602 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT02461602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02461602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
February 29, 2016
Completion date
May 31, 2018
Enrollment
251 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation